ConductScience.org, home

Paper30972754

Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.

Leonard A and 8 others. Br J Haematol, 2019. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery. Papers, record 30972754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30972754

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
PubMed
Journal
Br J Haematol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
2.46
iCite
Revised in PubMed
2025-05-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leonard AAlexishttps://orcid.org/0000-0003-4317-3879
2Bonifacino AAylin
3Dominical VMVenina M
4Luo MMin
5Haro-Mora JJJuan J
6Demirci SSelami
7Uchida NNaoya
8Pierciey FJ JrFrancis J
9Tisdale JFJohn F

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, Sickle CellMajor topic
Antigens, CD34Major topic
ErythropoiesisMajor topic
Hematopoietic Stem CellsMajor topic
Stress, PhysiologicalMajor topic
Adult
Female
Flow Cytometry
Humans
Inflammation
Male

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
ZIA HL006007Intramural NIH HHSUnited StatesZIAHL006007PubMedNIH RePORTER
ZIA HL006009Intramural NIH HHSUnited StatesZIAHL006009PubMedNIH RePORTER

Download CSV of grants

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129419425Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.Haematologica2018https://conductscience.org/library/papers/29419425PubMed
227820943CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.Nature2016https://conductscience.org/library/papers/27820943PubMed
327510901Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy.Sci Transl Med2016https://conductscience.org/library/papers/27510901PubMed
412480697SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.Blood2003https://conductscience.org/library/papers/12480697PubMed
526758915Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.Blood2016https://conductscience.org/library/papers/26758915PubMed
619995398Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.Br J Haematol2010https://conductscience.org/library/papers/19995398PubMed
78595612Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL8: C3 is not essential.Cardiovasc Res1995https://conductscience.org/library/papers/8595612PubMed
822264835Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-κB signaling pathway.Mol Immunol2012https://conductscience.org/library/papers/22264835PubMed
922901265Hematopoietic stem cell expansion: challenges and opportunities.Ann N Y Acad Sci2012https://conductscience.org/library/papers/22901265PubMed
1029472357Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.Haematologica2018https://conductscience.org/library/papers/29472357PubMed
119808852Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis.J Vasc Surg1998https://conductscience.org/library/papers/9808852PubMed
1226064103Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review.Adv Pharmacol Sci2015https://conductscience.org/library/papers/26064103PubMed
1319004988Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.J Leukoc Biol2009https://conductscience.org/library/papers/19004988PubMed
1411122087Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia.Br J Haematol2000https://conductscience.org/library/papers/11122087PubMed
1511985552Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease.Clin Lab Haematol2002https://conductscience.org/library/papers/11985552PubMed
1615145217Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.Exp Hematol2004https://conductscience.org/library/papers/15145217PubMed
179808586Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes.Blood1998https://conductscience.org/library/papers/9808586PubMed
1827601644Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27601644PubMed
199254660Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture.J Exp Med1997https://conductscience.org/library/papers/9254660PubMed
2028330619Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.Stem Cell Reports2017https://conductscience.org/library/papers/28330619PubMed

See all 73 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42219144Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction.Exp Hematol2026https://conductscience.org/library/papers/42219144PubMed
42052798Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease.Br J Haematol2026https://conductscience.org/library/papers/42052798PubMed
42008008Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.Blood Adv2026https://conductscience.org/library/papers/42008008PubMed
41991612Intravenous administration of ex vivo expanded human umbilical cord blood-derived CD34⁺ cells in a preterm hypoxic-ischemic encephalopathy mouse model.Sci Rep2026https://conductscience.org/library/papers/41991612PubMed
41905703Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.Transplant Cell Ther2026https://conductscience.org/library/papers/41905703PubMed
41830512Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview.Am J Hematol2026https://conductscience.org/library/papers/41830512PubMed
41741059Emerging Considerations in Transfusion Medicine: Hematopoietic Stem and Progenitor Cell Collection for Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Thalassemia.Clin Lab Med2026https://conductscience.org/library/papers/41741059PubMed
41282081IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell Anemia.Res Sq2025https://conductscience.org/library/papers/41282081PubMed
41253147Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche.Cell Rep Med2025https://conductscience.org/library/papers/41253147PubMed
40966451Hematopoietic stem cell therapy with gene modification to treat sickle cell disease.Stem Cells Transl Med2025https://conductscience.org/library/papers/40966451PubMed
40472294To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients.Blood Adv2025https://conductscience.org/library/papers/40472294PubMed
39633531Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia.Haematologica2025https://conductscience.org/library/papers/39633531PubMed
39568202From old to new: Repurposed drugs in the battle towards curing sickle cell disease.Br J Haematol2025https://conductscience.org/library/papers/39568202PubMed
39356871How I treat sickle cell disease with gene therapy.Blood2024https://conductscience.org/library/papers/39356871PubMed
39044427Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses.Mol Ther2024https://conductscience.org/library/papers/39044427PubMed
38941538Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation.Blood Adv2024https://conductscience.org/library/papers/38941538PubMed
38506770Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models.Cytotherapy2024https://conductscience.org/library/papers/38506770PubMed
38396832Reticulocyte Antioxidant Enzymes mRNA Levels versus Reticulocyte Maturity Indices in Hereditary Spherocytosis, β-Thalassemia and Sickle Cell Disease.Int J Mol Sci2024https://conductscience.org/library/papers/38396832PubMed
38262104Effect of voxelotor on murine bone marrow and peripheral blood with hematopoietic progenitor cell mobilization for gene therapy of sickle cell disease.Blood Cells Mol Dis2024https://conductscience.org/library/papers/38262104PubMed
38027257Genome editing for sickle cell disease: still time to correct?Front Pediatr2023https://conductscience.org/library/papers/38027257PubMed

See all 52 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30972754

GET https://conductscience.org/api/papers/v1/30972754/references?page=2